Global Generic Drug Market Projected to Reach $1.3 Trillion by 2027, Driven by Demand in Developing Nations

The global generic drug market is poised for significant expansion, with projections estimating it will reach $1.3 trillion by 2027, according to a recent industry webinar. Experts predict a compound annual growth rate (CAGR) of 9-10% for the sector, fueled primarily by increasing demand for affordable medicines, especially in developing nations. Several key trends, opportunities, and challenges are expected to shape the industry’s trajectory. The rising demand for complex generics will likely continue as more sophisticated molecules lose patent protection. Biosimilars will also continue to gain traction within the generics landscape, with over 60 already approved globally and more expected in the coming years. Companies operating in emerging markets will face increasing competition as these markets expand. Regulatory frameworks will evolve rapidly, with a continuous stream of guidelines and regulations designed to ensure the quality and safety of generic medications. Finally, digital transformation is underway in the generics industry, which is pushing companies to invest in digitalization to enhance efficiency, reduce costs, and improve patient outcomes.

Newsflash | Powered by GeneOnline AI
Date: April 14, 2025

Related posts:

VC Firm Sofinnova Partners Pulls In €1.2B to Deploy Across Life Sciences Investments Biosimilar Extrapolation Faces Regulatory Complexities Analysis: CDMO Partnerships Offer Pharmaceutical Firms Faster Market Entry and Cost Reduction in Drug Development Guide Explores Drug Pricing, Highlights Patent Expirations’ Impact

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後